LOGIN
Zoledronic acid affects men and women similarly in increasing bone mass after hip fracture
November 2013
Zoledronic acid affects men and women similarly in increasing bone mass after hip fracture
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Once-Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture
J Am Geriatr Soc. 2011 Nov;59(11):2084-90. doi: 10.1111/j.1532-5415.2011.03666.x. Epub 2011 Oct 21Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
1619 women and 508 men who underwent surgical repair for low-trauma hip fractures were randomized to either receive zoledronic acid (ZOL) or a placebo to determine the impact of ZOL on bone mineral density (BMD) in men and women surgical repair of hip fractures. Following assessments measured over 2 years, there were similar increases in the bone mass at the hip and femoral neck among both men and...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.